Quick verdict: ICHR vs INDI in 2026

In a direct ichr vs indi stock comparison 2026, Ichor Holdings (ICHR) holds a distinct edge over indie Semiconductor (INDI) across several fundamental metrics. ICHR emerges as the clear growth leader with substantially higher revenue growth, while it also demonstrates superior margin performance, being significantly less unprofitable. While both companies receive a high percentage of “Buy” ratings from analysts, INDI shows a modest positive target price upside of +0.2% compared to ICHR’s projected downside of -29.0%, making INDI the one with most immediate upside potential according to analyst price targets, although its fundamental and valuation metrics are considerably weaker. Not investment advice.

ICHR vs INDI: key metrics side by side

Full side-by-side comparison of ICHR and INDI across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-12.

ICHR vs INDI valuation comparison

When considering ICHR vs INDI fundamentals and valuation, both companies present significant challenges from a traditional valuation perspective due to their current unprofitability. Ichor Holdings (ICHR) trades at a P/E ratio of -52.53x, which, while negative, is dramatically better than indie Semiconductor (INDI)’s staggering P/E of -6190.66x. This vast difference highlights the extent of INDI’s current losses relative to its share price. Similarly, the Price-to-Book (P/B) ratio paints a stark picture: ICHR’s P/B is 3.99x, whereas INDI’s is an exceptionally high 2910.7x, indicating that INDI’s market capitalization is nearly 3,000 times its book value, suggesting an extremely speculative valuation based on future growth expectations rather than current assets.

Further emphasizing the valuation disparities in this ichr vs indi valuation, the Discounted Cash Flow (DCF) analysis provided presents deeply negative values for both. ICHR has a DCF of $3.78, implying a severe downside of -95.1% from its current price. However, INDI’s DCF is an even more concerning $-32.52, pointing to an astronomical downside of -786.1%. While neither company appears “cheap” by conventional metrics, ICHR’s valuation, though challenging, appears significantly less extreme and more grounded compared to INDI’s, which suggests a much higher degree of speculative premium priced into its stock.

ICHR vs INDI growth comparison

In the realm of growth, ICHR demonstrably outpaces INDI, making it the stronger candidate for growth-oriented investors looking at ichr vs indi earnings growth comparison. Ichor Holdings reported a TTM revenue of $947,652,000, significantly larger than indie Semiconductor’s revenue of $217,394,000. More importantly, ICHR achieved a year-over-year revenue growth of +11.6%, indicating a robust expansion in its core business. This contrasts sharply with INDI, which posted a mere +0.3% revenue growth, suggesting a near-stagnation in its top-line expansion in the most recent period.

Despite both companies operating with negative margins, ICHR’s ability to generate substantially higher revenue and maintain double-digit growth provides it with stronger momentum and a better foundation for future profitability. Strong revenue growth is often a precursor to improved financial health, especially for technology companies that may prioritize market share and scaling operations. For investors evaluating which stock to buy, ICHR’s superior revenue and growth trajectory position it as the company with more significant operational momentum and potential for scaling in the competitive technology sector, which is crucial for long-term viability and eventual profitability.

ICHR vs INDI profitability

When analyzing ichr vs indi profitability, Ichor Holdings exhibits a considerably less severe state of unprofitability compared to indie Semiconductor. ICHR’s net margin stands at -5.28%, a challenging but manageable figure, especially within growth-focused technology sectors. In stark contrast, INDI reports an alarming net margin of -69.76%, indicating that the company is losing nearly 70 cents for every dollar of revenue generated. This difference in net margin highlights a critical operational efficiency gap, with ICHR demonstrating much better cost control and a clearer path towards achieving positive net income.

Regarding other profitability metrics, both companies report N/A% for Return on Equity (ROE), likely due to negative equity or other accounting complexities often seen in unprofitable or rapidly expanding firms. However, the Free Cash Flow (FCF) yield further underscores ICHR’s stronger financial position. ICHR has an FCF yield of -0.63%, meaning it’s burning cash but at a relatively contained rate. INDI, on the other hand, shows a much higher cash burn with an FCF yield of -6.54%. This implies that INDI is consuming cash at a rate more than ten times greater than ICHR relative to its market capitalization, raising concerns about its long-term liquidity and sustainability without further financing. For the ichr vs indi dividend and margins analysis, neither company pays dividends (both 0% yield), further underscoring their focus on reinvestment or covering operational losses.

Analyst ratings: ICHR vs INDI

Analyst sentiment for both ICHR and INDI presents an interesting dichotomy when comparing their ‘Buy’ ratings and price targets. Ichor Holdings (ICHR) is covered by 14 analysts, with a strong 85.7% recommending a “Buy” rating, aligning with a consensus of “Buy.” However, the average analyst price target for ICHR is $54.6, which represents a significant -29.0% downside from its current trading price of $76.95. This suggests that while analysts generally view ICHR favorably, they believe the stock may be currently overvalued relative to its near-term potential, or that there are substantial headwinds foreseen.

Conversely, indie Semiconductor (INDI), covered by 7 analysts, also commands an 85.7% “Buy” rating and a “Buy” consensus, mirroring ICHR in terms of positive sentiment percentage. Crucially, INDI’s average analyst price target is $4.75, which offers a modest +0.2% upside from its current price of $4.74. This indicates that while the upside is minimal, analysts believe INDI’s current price is fair or slightly undervalued, unlike ICHR. Therefore, for investors prioritizing immediate potential upside based on analyst forecasts in this ichr vs indi analyst ratings and recommendations, INDI appears to have the edge, even if its underlying fundamental metrics are considerably weaker than ICHR’s, highlighting a different set of expectations for each company.

Should I buy ICHR or INDI stock in 2026?

When considering should i buy ichr or indi stock 2026, the decision largely depends on your investment strategy and risk tolerance, as both companies operate in the technology sector with varying degrees of financial health. For growth investors, ICHR appears to be the more compelling option. Its robust 11.6% year-over-year revenue growth significantly outpaces INDI’s meager 0.3%. Furthermore, ICHR’s substantially larger revenue base of $947,652,000 suggests a more established market presence and stronger operational momentum, which is critical for long-term growth potential in a dynamic industry.

For value investors, assessing ichr vs indi fundamentals and valuation is complex given both companies are currently unprofitable. However, ICHR presents a relatively less extreme valuation picture. While both P/E ratios are negative (ICHR at -52.53x vs INDI at -6190.66x), ICHR’s P/B ratio of 3.99x is dramatically more reasonable than INDI’s exorbitant 2910.7x. The DCF analysis also points to ICHR as being less “overvalued” by this metric (-95.1% downside) compared to INDI (-786.1% downside). While neither stock fits a traditional value profile, ICHR’s metrics indicate a more grounded valuation, even with its current challenges.

For income-focused investors, neither ICHR nor INDI are suitable choices, as both companies have a 0% dividend yield. Their current financial positions, characterized by negative net margins and free cash flow yields, indicate that any available capital is likely being reinvested into operations, used to cover losses, or potentially raised through financing, rather than being distributed to shareholders. Therefore, if dividend income is a priority, investors should look elsewhere. This is not investment advice; please conduct your own due diligence before making any investment decisions.

More ICHR and INDI comparisons

ICHR full stock analysis · INDI full stock analysis · All stock comparisons

FAQ: ICHR vs INDI